Article
Christopher S. Henney Appointed Chairman of Anthera
Author(s):
Christopher S. Henney has been appointed chairman of the board of Anthera Pharmaceuticals Inc. (San Mateo, CA).
Christopher S. Henney has been appointed chairman of the board of Anthera Pharmaceuticals Inc. (San Mateo, CA). Henney has served as an independent director of Anthera since 2006. He is a co-founder of three major publicly held US biotechnology companies: Immunex‚ ICOS, and Dendreon‚ and has been associated with the formation of several others. Most recently Henney has served as chairman and CEO of Dendreon, and as chairman of SGX Pharmaceuticals and of Oncothyreon.
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
